ConductScience.org, home

Paper9607841

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.

Anttila M and 3 others. J Infect Dis, 1998. Cited by 126 papers, by iCite.

Cite this record

ConductScience Library. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. Papers, record 9607841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9607841

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
PubMed
Journal
J Infect Dis
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
126
iCite
Relative citation ratio, by iCite
3.65
iCite
Revised in PubMed
2022-03-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Anttila MM
2Eskola JJ
3Ahman HH
4Käyhty HH

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, BacterialMajor topic
Antibody AffinityMajor topic
Bacterial VaccinesMajor topic
Immunoglobulin GMajor topic
Meningococcal VaccinesMajor topic
Polysaccharides, BacterialMajor topic
Streptococcus pneumoniaeMajor topic
Vaccines, ConjugateMajor topic
Diphtheria Toxoid
Humans
Infant
Pneumococcal Vaccines
Tetanus Toxoid

Source PubMed

Download CSV of topics

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.

PMIDTitleJournalYearIn PapersSource
40804314Approaches to assess new pneumococcal vaccines for immunogenicity, development and licensure.Hum Vaccin Immunother2025https://conductscience.org/library/papers/40804314PubMed
40128220A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model.Nat Commun2025https://conductscience.org/library/papers/40128220PubMed
39257585The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines.Front Immunol2024https://conductscience.org/library/papers/39257585PubMed
36210249Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation.Vaccine2022https://conductscience.org/library/papers/36210249PubMed
34195422Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice.Heliyon2021https://conductscience.org/library/papers/34195422PubMed
30515161Protection Against Invasive Infections in Children Caused by Encapsulated Bacteria.Front Immunol2018https://conductscience.org/library/papers/30515161PubMed
30374357
The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses.
Front Immunol2018https://conductscience.org/library/papers/30374357PubMed
29299402Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea.Pneumonia (Nathan)2017https://conductscience.org/library/papers/29299402PubMed
28433580Description of a novel multiplex avidity assay for evaluating HPV antibodies.J Immunol Methods2017https://conductscience.org/library/papers/28433580PubMed
27178810Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses.J Control Release2016https://conductscience.org/library/papers/27178810PubMed
26939935Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.Clin Exp Immunol2016https://conductscience.org/library/papers/26939935PubMed
25506706Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.PLoS One2014https://conductscience.org/library/papers/25506706PubMed
24058629Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses.PLoS One2013https://conductscience.org/library/papers/24058629PubMed
23660844Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A.Immunol Res2014https://conductscience.org/library/papers/23660844PubMed
23378166Correlation of pneumococcal antibody concentration and avidity with patient clinical and immunologic characteristics.J Clin Immunol2013https://conductscience.org/library/papers/23378166PubMed
23153440Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease.Vaccine2013https://conductscience.org/library/papers/23153440PubMed
22285687Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals.Mol Cell Probes2012https://conductscience.org/library/papers/22285687PubMed
21628671Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine.J Infect Dis2011https://conductscience.org/library/papers/21628671PubMed
21539882Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.Vaccine2011https://conductscience.org/library/papers/21539882PubMed
21184126Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients.Eur J Clin Microbiol Infect Dis2011https://conductscience.org/library/papers/21184126PubMed

See all 46 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9607841

GET https://conductscience.org/api/papers/v1/9607841/cited_by?page=2